This site is intended for health professionals only

Prostate cancer drug probed by FDA

teaser

The drugs suppress testosterone, which aids the growth of prostate cancer tumours and is also occasionally used by women to treat pain for uterine fibroids.

Slightly higher rates of diabetes and heart disease in patients taking the drugs have been shown in preliminary data from six studies, but the FDA says it has not conclusively linked the drugs to health problems.

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

It told doctors to be on the lookout for early signs of heart disease and diabetes in patients.

Drugs under scrutiny include AstraZeneca’s Zoladex, Pfizer’s Synarel and Abbott Laboratory’s Lupron, among others.

Copyright Press Association 2010
US Food and Drug Administration






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x